PubMed Health⌕ Search

PubMed · 10661031

Newly developing endoscopic devices--shadow optics and micromachine.

Abstract

Based on the newly-developed engineering technologies, many kinds of useful equipment have been available for minimally invasive surgery. Recently the time to connect clinical needs and advanced technologies has become faster. In this article, we have summarized the recent technologies for endoscopic surgeries. Shadow optic technologies for better geometric perception using dual illumination in a conventional 2-D monitor and "Overview optics" for a panoramic view with an additional visual system are introduced. Micromachine technology is very close to practical implementation for minimally invasive surgeries. Virtual Biopsy is the one of the hottest topics for the next generation of endoscopy. Stereoscopic and volumetric vision systems are still on the way, which should overcome the irritating goggles and stereo display devices. As well as operational theater that integrates all the required equipment with a computer-based system, including voice recognition, still requires the standard protocols to connect many kinds of devices from different manufacturers.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y J Chee, S W Lee, K Park. 1999. Newly developing endoscopic devices--shadow optics and micromachine.. https://doi.org/10.3349/ymj.1999.40.6.550

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗